243 related articles for article (PubMed ID: 19577162)
1. Acute myeloid leukemia.
Heerema-McKenney A; Arber DA
Hematol Oncol Clin North Am; 2009 Aug; 23(4):633-54. PubMed ID: 19577162
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of cytogenetics in acute myeloid leukemia.
Mrózek K; Heinonen K; de la Chapelle A; Bloomfield CD
Semin Oncol; 1997 Feb; 24(1):17-31. PubMed ID: 9045301
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of cytogenetic findings in adults with acute myeloid leukemia.
Mrózek K; Heinonen K; Bloomfield CD
Int J Hematol; 2000 Oct; 72(3):261-71. PubMed ID: 11185980
[TBL] [Abstract][Full Text] [Related]
4. Realistic pathologic classification of acute myeloid leukemias.
Arber DA
Am J Clin Pathol; 2001 Apr; 115(4):552-60. PubMed ID: 11293903
[TBL] [Abstract][Full Text] [Related]
5. [WHO classification of acute myeloid leukaemia (AML) and the myelodysplastic syndrome (MDS)].
Haferlach T; Schoch C
Dtsch Med Wochenschr; 2002 Mar; 127(9):447-50. PubMed ID: 11870559
[No Abstract] [Full Text] [Related]
6. [Haematological characteristics, FAB and WHO classification of 153 cases of myeloid acute leukaemia in Tunisia].
Braham-Jmili N; Sendi-Senana H; Labiadh S; Ben Abdelali R; Ben Abdelaziz A; Khelif A; Saad A; Kortas M
Ann Biol Clin (Paris); 2006; 64(5):457-65. PubMed ID: 17040877
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia.
Schoch C; Schnittger S; Kern W; Dugas M; Hiddemann W; Haferlach T
Haematologica; 2003 Mar; 88(3):351-2. PubMed ID: 12651278
[No Abstract] [Full Text] [Related]
8. Long-term outcomes for unselected patients with acute myeloid leukemia categorized according to the World Health Organization classification: a single-center experience.
Yanada M; Suzuki M; Kawashima K; Kiyoi H; Kinoshita T; Emi N; Saito H; Naoe T
Eur J Haematol; 2005 May; 74(5):418-23. PubMed ID: 15813916
[TBL] [Abstract][Full Text] [Related]
9. [The diagnosis of acute myeloid leukaemia enhanced by using DNA microarrays].
Löwenberg B; Delwel HR; Valk PJ
Ned Tijdschr Geneeskd; 2005 Mar; 149(12):623-5. PubMed ID: 15813428
[TBL] [Abstract][Full Text] [Related]
10. NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia.
Falini B; Mecucci C; Saglio G; Lo Coco F; Diverio D; Brown P; Pane F; Mancini M; Martelli MP; Pileri S; Haferlach T; Haferlach C; Schnittger S
Haematologica; 2008 Mar; 93(3):439-42. PubMed ID: 18268276
[TBL] [Abstract][Full Text] [Related]
11. Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances.
Mrózek K; Döhner H; Bloomfield CD
Curr Opin Hematol; 2007 Mar; 14(2):106-14. PubMed ID: 17255787
[TBL] [Abstract][Full Text] [Related]
12. Combination of broad molecular screening and cytogenetic analysis for genetic risk assignment and diagnosis in patients with acute leukemia.
Meyer-Monard S; Parlier V; Passweg J; Mühlematter D; Hess U; Bargetzi M; Kühne T; Cabrol C; Gratwohl A; Jotterand M; Tichelli A
Leukemia; 2006 Feb; 20(2):247-53. PubMed ID: 16408102
[TBL] [Abstract][Full Text] [Related]
13. Detection of the CBFB/MYH11 fusion gene in de novo acute myeloid leukemia (AML): a single-institution study of 224 Japanese AML patients.
Monma F; Nishii K; Shiga J; Sugahara H; Lorenzo F; Watanabe Y; Kawakami K; Hosokai N; Yamamori S; Katayama N; Shiku H
Leuk Res; 2007 Apr; 31(4):471-6. PubMed ID: 17052753
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of cytogenetic aberrations in childhood acute myeloid leukaemia. A study of the Swiss Paediatric Oncology Group (SPOG).
Betts DR; Ammann RA; Hirt A; Hengartner H; Beck-Popovic M; Kuhne T; Nobile L; Caflisch U; Wacker P; Niggli FK
Eur J Haematol; 2007 Jun; 78(6):468-76. PubMed ID: 17419750
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis of myeloid hematologic malignancies: contributions of the 2001 World Health Organization (WHO) classification].
Leymarie V; Galoisy AC; Falkenrodt A; Lessard M
Ann Biol Clin (Paris); 2004; 62(5):513-20. PubMed ID: 15355801
[TBL] [Abstract][Full Text] [Related]
16. Laboratory diagnosis of acute myeloid leukaemia.
Swirsky DM; Richards SJ
Best Pract Res Clin Haematol; 2001 Mar; 14(1):1-17. PubMed ID: 11355921
[TBL] [Abstract][Full Text] [Related]
17. Chromosome aberrations in de novo acute myeloid leukemia patients in Kuwait.
Al Bahar S; Pandita R; Bavishi K; Kreze O; Nath S
Neoplasma; 2004; 51(3):223-7. PubMed ID: 15254677
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetics in acute myeloid leukemia.
Schoch C; Haferlach T
Curr Oncol Rep; 2002 Sep; 4(5):390-7. PubMed ID: 12162912
[TBL] [Abstract][Full Text] [Related]
19. The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia.
Grimwade D
Best Pract Res Clin Haematol; 2001 Sep; 14(3):497-529. PubMed ID: 11640867
[TBL] [Abstract][Full Text] [Related]
20. Karyotype refinement in five patients with acute myeloid leukemia using spectral karyotyping.
Calabrese G; Fantasia D; Spadano A; Morizio E; Di Bartolomeo P; Palka G
Haematologica; 2000 Nov; 85(11):1219-21. PubMed ID: 11064476
[No Abstract] [Full Text] [Related]
[Next] [New Search]
